PT - JOURNAL ARTICLE AU - Sharma, Amit AU - Chauhan, Ekansh AU - Uppin, Megha S AU - Rajasekhar, Liza AU - Jawahar, C V AU - Vinod, P K TI - Lupus Nephritis Subtype Classification with only Slide Level labels AID - 10.1101/2023.12.03.23299357 DP - 2024 Jan 01 TA - medRxiv PG - 2023.12.03.23299357 4099 - http://medrxiv.org/content/early/2024/03/15/2023.12.03.23299357.short 4100 - http://medrxiv.org/content/early/2024/03/15/2023.12.03.23299357.full AB - Lupus Nephritis classification has historically relied on labor-intensive and meticulous glomerular-level labeling of renal structures in whole slide images (WSIs). However, this approach presents a formidable challenge due to its tedious and resource-intensive nature, limiting its scalability and practicality in clinical settings. In response to this challenge, our work introduces a novel methodology that utilizes only slide-level labels, eliminating the need for granular glomerular-level labeling. A comprehensive multi-stained lupus nephritis digital histopathology WSI dataset was created from the Indian population, which is the largest of its kind. LupusNet, a deep learning MIL-based model, was developed for the sub-type classification of LN. The results underscore its effectiveness, achieving an AUC score of 91.0%, an F1-score of 77.3%, and an accuracy of 81.1% on our dataset in distinguishing membranous and diffused classes of LN.Competing Interest StatementThe authors have declared no competing interest.Funding StatementThis study was funded by IHub-Data, IIIT Hyderabad (H1-002)Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:Ethics Committee of Nizam's Institute Of Medical Sciences, Hyderabad, India, gave ethical approval for this workI confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.YesThe dataset generated and/or analyzed during the current study is available from the authors on reasonable request within the terms of the data use agreement and compliance with ethical and legal requirements.